Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease ...
Biochemistry
Nov 28, 2010
0
0
(PhysOrg.com) -- Entropy can decrease, according to a new proposal - but the process would destroy any evidence of its existence, and erase any memory an observer might have of it. It sounds like the plot to a weird sci-fi ...
An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.
Biotechnology
Mar 9, 2009
0
0
